References
- Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce. Neurorehabil Neural Repair. 2017;31(9):793–799. doi:https://doi.org/10.1177/1545968317732668.
- Lance JW. The control of muscle tone, reflexes, and movement: robert wartenberg lecture. Neurology. 1980;30(12):1303–1313. doi:https://doi.org/10.1212/WNL.30.12.1303.
- Reichel G, Wissel J, Jost W. Therapieleitfaden Spastik-Dystonien, 5. Auflage. 14–64. Germany: UNI-MED Verlag AG; 2012
- Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27(1–2):2–6. doi:https://doi.org/10.1080/09638280400014576.
- Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke. Neurology. 2013;80:S20–6. doi:https://doi.org/10.1212/WNL.0b013e31827624a7.
- Wissel J, Manack A, Brainin M. Toward an epidemiology of poststroke spasticity. Neurology. 2013;80:S13–19. doi:https://doi.org/10.1212/WNL.0b013e3182762448.
- Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol. 2010;257(7):1067–1972. doi:https://doi.org/10.1007/s00415-010-5463-1.
- Urban PP, Wolf T, Uebele M, et al. Occurrence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41:2016–2020. doi:https://doi.org/10.1161/STROKEAHA.110.581991.
- Opheim A, Danielsson A, Alt Murphy M, et al. Early prediction of long-term upper limb spasticity after stroke: part of the SALGOT study. Neurology. 2015;85(10):873–880. doi:https://doi.org/10.1212/WNL.0000000000001908.
- Lundström E, Smits A, Terént A, et al. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med. 2010;42(4):296–301. doi:https://doi.org/10.2340/16501977-0509.
- Gracies JM. Pathophysiology of spastic paresis. I: paresis and soft tissue changes. Muscle Nerve. 2005;31(5):535–551. doi:https://doi.org/10.1002/mus.20284.
- Lieber RL, Steinman S, Barash IA, Chambers H. Structural and functional changes in spastic skeletal muscle. Muscle Nerve. 2004;29(5):615–627. doi:https://doi.org/10.1002/mus.20059.
- Hefter H, Jost WH, Reissig A, et al. Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment? Int J Rehabil Res. 2012;35(3):227–233. doi:https://doi.org/10.1097/MRR.0b013e328353e3d4.
- Wissel J, Verrier M, Simpson DM, et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PMR. 2015;7(1):60–67. doi:https://doi.org/10.1016/j.pmrj.2014.08.946.
- Brainin M, Norrving B, Sunnerhagen KS, et al. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke. 2011;6(1):42–46. doi:https://doi.org/10.1111/j.1747-4949.2010.00539.x.
- O’Brien CF. Treatment of spasticity with botulinum toxin. Clin J Pain. 2002;18(Suppl 6):S182–S190. doi:https://doi.org/10.1097/00002508-200211001-00011.
- Picelli A, Tamburin S, Dambruoso F, et al. Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. Eur J Phys Rehabil Med. 2014;50(5):489–494.
- Kong KH, Lee J, Chua KS. Occurrence and temporal evolution of upper limb spasticity in stroke patients admitted to a rehabilitation unit. Arch Phys Med Rehabil. 2012;93(1):143–148. doi:https://doi.org/10.1016/j.apmr.2011.06.027.
- Sommerfeld DK, Eek EUB, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35(1):134–139. doi:https://doi.org/10.1161/01.STR.0000105386.05173.5E.
- Moura Rde C, Fukujima MM, Aguiar AS, et al. Predictive factors for spasticity among ischemic stroke patients. Arq Neuropsiquiatr. 2009;67(4):1029–1036.
- Brötz D, Götz A, Müller H, Karnath HO. Physiotherapeutische Diagnostik und Therapie der Pusher-Symptomatik. Z.f .Physiotherapeuten. 2002;54:365–376.
- Kool J. Neglect im Alltag beurteilen Assessment: catherine Bergego Scale. physiopraxis. 2006;4(5):30–31. doi:https://doi.org/10.1055/s-0032-1307993.
- Paternostro-Sluga T, Grim-Stieger M, Posch M, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008;40(8):665–671. doi:https://doi.org/10.2340/16501977-0235.
- Freimüller M, Fheodoroff K. Neurorehabilitation nach Schlaganfall. Wiener Med Wochenschr. 2003;153(1–2):25–28. doi:https://doi.org/10.1046/j.1563-258X.2003.02110.x.
- Runge M, Rehfeld G. Geriatrische Rehabilitation im therapeutischen Team. Stuttgart: Thieme; 1995.
- Holden MK, Gill KM, Magliozzi MR. Gait assessment for neurologically impaired patients. Standards for outcome assessment. Phys Ther. 1986;66(10):1530–1539. doi:https://doi.org/10.1093/ptj/66.10.1530.
- Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Psychiatr Res. 1975;12(3):189–198. doi:https://doi.org/10.1016/0022-3956(75)90026-6.
- Platz T, Vuadens P, Eickhof C, et al. REPAS, a summary rating scale for resistance to passive movement: item selection, reliability and validity. Disabil Rehabil. 2008;30(1):44–53. doi:https://doi.org/10.1080/09638280701191743.
- Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35–41. doi:https://doi.org/10.1161/01.STR.24.1.35.
- Welmer AK, Widén Holmqvist L, Sommerfeld DK. Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke. Eur J Neurol. 2010;17(5):720–725. doi:https://doi.org/10.1111/j.1468-1331.2009.02915.x.
- Welmer AK, von Arbin M, Widén Holmqvist L, et al. Spasticity and its association with functioning and health-related quality of life 18 months after stroke. Cerebrovascular Dis. 2006;21(4):247–253. doi:https://doi.org/10.1159/000091222.
- Leathley MJ, Gregson JM, Moore AP, et al. Predicting spasticity after stroke in those surviving to 12 months. Clin Rehabil. 2004;18(4):438–443. doi:https://doi.org/10.1191/0269215504cr727oa.
- Triccas LT, Kennedy N, Smith T, Pomeroy V. Predictors of upper limb spasticity after stroke? A systematic review and meta-analysis. Physiotherapy. 2019;105(2):163–173. doi:https://doi.org/10.1016/j.physio.2019.01.004.
- Cheung DK, Climans SA, Black SE, Gao F, Szilagyi GM, Mochizuki G. Lesion characteristics of individuals with upper limb spasticity after stroke. Neurorehabil Neural Repair. 2016;30(1):63–70. doi:https://doi.org/10.1177/1545968315585357.
- Ryu JS, Lee JW, Lee SI, Chun MH. Factors predictive of spasticity and their effects on motor recovery and functional outcomes in stroke patients, top. Stroke Rehabil. 2010;17(5):380–388. doi:https://doi.org/10.1310/tsr1705-380.
- Rosales RL, Balcaitiene J, Berard H, et al. Early abobotulinumtoxinA (Dysport®) in post-stroke adult upper limb spasticity: ONTIME pilot study. Toxins (Basel). 2018;10(7):253. doi:https://doi.org/10.3390/toxins10070253.
- Wissel J, Fheodoroff K, Hoonhorst M, et al. Effectiveness of abobotulinumtoxin A in post-stroke upper limb spasticity in relation to timing of treatment. Front Neurol. 2020;11:104. doi:https://doi.org/10.3389/fneur.2020.00104.